Introduction
For many women, an irregular or absent period is the first sign that something is wrong - the symptom that eventually leads to a PCOS diagnosis. And yet, once that diagnosis is made, the explanation often stops there.
"Irregular periods are part of PCOS." Full stop.
What is rarely explained is why PCOS disrupts the menstrual cycle, what is happening hormonally during those long, unpredictable cycles, what it means metabolically when ovulation is absent, and - most importantly - what actually happens to cycle regularity when the underlying metabolic drivers are addressed.
This article answers all of those questions.
Understanding your cycle in the context of PCOS is not just academically useful. It changes how you relate to your body, what you pay attention to, and what interventions you prioritise. Your irregular cycle is not simply a feature of your diagnosis. It is a metabolic signal - and it is worth learning to read it.
What a Normal Menstrual Cycle Actually Involves
To understand why PCOS disrupts the cycle, it helps to first understand what a normal cycle actually requires.
A typical menstrual cycle - conventionally described as 28 days, though 21–35 days is the clinical normal range - is orchestrated by a precise hormonal sequence involving the hypothalamus, pituitary gland, and ovaries.
The follicular phase begins on day one of menstruation. The hypothalamus releases GnRH (gonadotropin-releasing hormone), which signals the pituitary to release FSH (follicle-stimulating hormone). FSH stimulates the development of several ovarian follicles - fluid-filled sacs each containing an egg. As follicles develop, they produce increasing amounts of oestrogen.
Ovulation occurs when rising oestrogen reaches a threshold that triggers a surge of LH (luteinising hormone) from the pituitary. This LH surge causes the dominant follicle to rupture and release an egg - typically around day 14 in a 28-day cycle.
The luteal phase follows ovulation. The ruptured follicle transforms into the corpus luteum, which produces progesterone - the hormone that prepares the uterine lining for potential implantation and, critically, provides the calming, stabilising hormonal environment of the second half of the cycle. If fertilisation does not occur, the corpus luteum degenerates, progesterone falls, and menstruation begins.
The entire sequence depends on precise hormonal communication and adequate metabolic conditions. In PCOS, multiple points in this sequence are disrupted simultaneously.
How PCOS Disrupts the Cycle: The Hormonal Mechanism
The LH/FSH Imbalance
In women with PCOS, the pituitary produces LH and FSH in an altered ratio - typically elevated LH relative to FSH. This is one of the most consistent hormonal findings in PCOS and is measurable on a day 2–5 blood test.
The consequences are significant:
- Elevated LH chronically stimulates the ovarian theca cells to produce androgens - testosterone and androstenedione - before ovulation occurs
- Relatively low FSH means follicles are partially stimulated but cannot complete their development - they grow to a certain point and then stall, remaining as small, immature follicles
- Without a dominant follicle completing development, the oestrogen surge required to trigger the LH peak does not occur
- Without an LH peak, ovulation does not happen
- Without ovulation, the corpus luteum does not form, progesterone is not produced, and the luteal phase does not occur
The result is a cycle that stalls in the follicular phase - oestrogen rises partially, multiple small follicles accumulate in the ovaries (the polycystic appearance on ultrasound), but the cycle never completes. The uterine lining continues to build under oestrogen stimulation without the opposing, stabilising effect of progesterone - until it eventually sheds unpredictably, producing an irregular bleed that is not a true ovulatory period.
Insight
The bleed that occurs during an anovulatory PCOS cycle is not the same as a true menstrual period. A true period is the result of progesterone withdrawal following ovulation. An anovulatory bleed is the result of the uterine lining becoming unstable under prolonged, unopposed oestrogen stimulation. This distinction matters clinically - it explains why irregular PCOS bleeds can be unpredictable in timing, duration, and flow, and why the absence of bleeding does not mean the uterine lining is not building.
Insulin Resistance and the Hormonal Cascade
Insulin resistance is at the heart of the cycle disruption in PCOS - and this is the mechanism that makes the metabolic approach to cycle regulation both logical and effective.
Chronically elevated insulin has direct effects on the HPO (hypothalamic-pituitary-ovarian) axis:
At the hypothalamus: High insulin amplifies GnRH pulse frequency, which skews pituitary output toward more LH relative to FSH - directly creating the LH/FSH imbalance described above.
At the ovary: Insulin acts synergistically with LH on theca cells, amplifying androgen production beyond what LH alone would produce. Elevated insulin also sensitises follicles to LH stimulation while simultaneously impairing FSH receptor activity - promoting androgen production while blocking follicle maturation.
On SHBG: As covered across the cluster, elevated insulin suppresses SHBG - raising free androgen levels, further disrupting follicle development, and reinforcing the cycle of anovulation.
For the full detail on how insulin drives hormonal dysregulation in PCOS: High Insulin and PCOS: Why It Disrupts Hormones and PCOS and Insulin Resistance: What's Really Driving Your Symptoms
Inflammation and Ovulation
Chronic low-grade inflammation - detailed in PCOS and Inflammation - directly impairs ovarian function and ovulation through multiple mechanisms:
- Inflammatory cytokines (IL-1β, TNF-α) in ovarian follicular fluid impair follicle maturation and egg quality
- Systemic inflammation activates the HPA axis, raising cortisol - which directly suppresses GnRH pulsatility and LH secretion
- Oxidative stress within the ovarian environment damages follicular cells and reduces the probability of successful ovulation even when the hormonal sequence is partially intact
This explains why women with PCOS whose inflammation is high - driven by poor diet, poor sleep, chronic stress, or gut dysbiosis - tend to have worse cycle irregularity than those whose inflammatory burden is lower, even when androgen and insulin levels appear similar.
The Cortisol–Cycle Connection
Cortisol and the reproductive axis are in direct competition for hormonal resources. Under chronic stress - whether physiological or psychological - the body prioritises cortisol production over reproductive hormone production, suppressing GnRH pulsatility and reducing LH secretion.
This is an evolutionarily logical response - reproduction is deprioritised during perceived threat - but in women with PCOS where HPA axis dysregulation is a chronic feature rather than an acute response, it contributes to persistent anovulation independently of insulin or androgen levels.
Women with PCOS who notice their cycles become longer or more erratic during periods of high stress are experiencing this mechanism directly. The cortisol–cycle connection is covered in full in Cortisol and PCOS
What Long, Irregular Cycles Mean for Your Health
Beyond the inconvenience of unpredictable bleeding, long and anovulatory cycles have specific health implications that are worth understanding - both as motivation for addressing the root cause and as context for clinical monitoring.
Progesterone Deficiency
Every anovulatory cycle is a cycle without progesterone. The consequences extend well beyond cycle regularity:
Mood and anxiety: As covered in PCOS and Anxiety, progesterone metabolites are the body's primary natural anxiolytics. Chronic anovulation means chronic progesterone deficiency - contributing directly to the anxiety, poor sleep, and mood instability prevalent in PCOS.
Sleep quality: Progesterone has sedating and sleep-promoting properties. Without adequate progesterone, sleep architecture is affected - particularly slow-wave deep sleep.
Bone health: Progesterone supports bone density alongside oestrogen. Chronic anovulation in younger women is a risk factor for reduced bone density over time.
Unopposed Oestrogen and Endometrial Health
During anovulatory cycles, the uterine lining is exposed to oestrogen without the opposing, differentiating effect of progesterone. Over time, this unopposed oestrogen stimulation increases the risk of endometrial hyperplasia - abnormal thickening of the uterine lining - which is a recognised risk factor for endometrial cancer in women with long-standing anovulation.
This is one of the most clinically significant reasons why very long or absent cycles in PCOS warrant clinical management - not just monitoring. Women who go extended periods (three months or more) without a period should discuss endometrial monitoring with their GP or gynaecologist.
TIP If you are tracking your cycles - which is genuinely useful in PCOS for identifying patterns and monitoring the impact of interventions - consider using a symptom-tracking app alongside basic basal body temperature (BBT) charting. A sustained temperature rise in the second half of the cycle is the most accessible indicator that ovulation has occurred. If your temperature pattern shows no second-phase rise month after month, this confirms anovulation and provides useful data for your clinical team.
Metabolic Risk Over Time
Anovulatory cycles are a marker of ongoing metabolic dysregulation - and the research shows that women with more severe cycle irregularity have worse metabolic markers over time, including higher insulin, higher androgens, and a greater long-term risk of type 2 diabetes and cardiovascular disease.¹
This is not meant to alarm. It is meant to reframe cycle regularity as a metabolic health indicator - one of the most accessible, free, and informative data points available about how your PCOS management is tracking over time. Improving cycle regularity is not just a quality-of-life outcome. It is a metabolic health outcome.
What Actually Restores Cycle Regularity
The good news - and it is genuinely good news - is that the menstrual cycle is responsive. When the underlying metabolic drivers of anovulation are addressed, ovulation often resumes. This is one of the clearest demonstrations that the metabolic approach to PCOS is working.
Improving Insulin Sensitivity
Because insulin resistance is the primary driver of the LH/FSH dysregulation and androgen excess that underlie anovulation in PCOS, improving insulin sensitivity is the most upstream and most effective intervention for cycle regularity.
Clinical studies consistently show that reducing fasting insulin in PCOS - through dietary intervention, exercise, and targeted supplementation - produces meaningful improvements in ovulation rates and cycle regularity, independent of weight loss.² This is an important distinction: it is the hormonal environment that matters, not just the number on the scale.
As insulin levels fall, the LH pulse frequency normalises, the LH/FSH ratio moves toward balance, androgen production decreases, SHBG rises, and the ovarian environment becomes increasingly conducive to follicle maturation and ovulation.
The dietary framework most directly relevant: Best Diet for PCOS and Insulin Resistance and How to Balance Blood Sugar with PCOS
Reducing Inflammatory Load
Given inflammation's direct effects on ovarian function and the HPO axis, anti-inflammatory intervention is a genuine cycle regularity intervention - not just a metabolic one. Women who address inflammatory load through dietary change, sleep improvement, and stress management consistently report improvements in cycle length and regularity as part of their broader metabolic response.
Full detail: PCOS and Inflammation
Exercise: The Right Kind
Resistance training and moderate daily movement improve insulin sensitivity and reduce inflammatory load - both of which support ovulation. As covered in PCOS and Exercise, excessive high-intensity exercise can suppress the HPO axis further through cortisol elevation - making exercise type and volume genuinely relevant to cycle outcomes.
Targeted Nutritional Support
Several supplements have specific evidence for improving ovulation rates and cycle regularity in PCOS:
Inositol - the most well-evidenced supplement for cycle regularity in PCOS. Multiple clinical trials show myo-inositol supplementation improves ovulation rates, reduces LH/FSH ratio, and shortens cycle length in women with PCOS.³ The mechanism is direct: inositol improves insulin receptor sensitivity, reducing the hyperinsulinaemia that drives LH excess and anovulation.
Vitamin D - deficiency is independently associated with worse cycle irregularity in PCOS, and correction of deficiency improves cycle regularity as part of its broader metabolic effect.⁴
NAC - multiple trials show NAC supplementation improves ovulation rates in PCOS, comparable to metformin in some studies, through its insulin-sensitising and antioxidant mechanisms.⁵
Magnesium - supports insulin sensitivity and HPA axis regulation, with downstream benefits for the cortisol–cycle connection.
For the complete evidence-graded supplement guide: PCOS Supplements: What the Evidence Actually Says
Managing Cortisol and Sleep
Given the direct suppressive effect of cortisol on GnRH pulsatility, stress management and sleep quality are cycle regularity interventions in the most literal sense. Women who address sleep and cortisol as part of a broader PCOS approach consistently report this as one of the areas where they notice change - cycles that were 60, 90, or 120 days gradually shortening toward a more regular pattern.
Tracking Your Cycle as a Metabolic Health Tool
One of the most practically valuable things any woman with PCOS can do is begin tracking her cycle with more than just bleed dates - and use the pattern as ongoing feedback on her metabolic health.
What to track:
- Cycle length (day 1 of one bleed to day 1 of the next)
- Bleed duration and character (light, heavy, clotty, spotting)
- Basal body temperature (BBT) daily - a sustained temperature rise of approximately 0.2°C indicates ovulation has occurred
- Cervical mucus changes - the appearance of clear, stretchy, egg-white consistency mucus indicates approaching ovulation and rising oestrogen
- Associated symptoms - energy, mood, skin, bloating, cravings - which often follow a hormonal pattern once cycles become more regular
As metabolic health improves, the cycle pattern changes in predictable ways: cycles gradually shorten from very long toward a more regular range, BBT charts begin to show a biphasic pattern (temperature rise in the second half) indicating ovulation is resuming, and the associated symptoms shift in character.
This tracking data is also genuinely useful for your clinical team - it provides a longitudinal picture of your hormonal pattern that a single blood test cannot capture.
Pharmaceutical Options: Context and Considerations
This article has focused on the metabolic root cause approach because that is both the most underaddressed and, in the long term, the most durable approach to cycle regularity in PCOS. But pharmaceutical options are part of the clinical landscape and worth understanding in context.
The oral contraceptive pill is the most commonly prescribed option for cycle regulation in PCOS. It works by suppressing the HPO axis entirely and replacing the cycle with a withdrawal bleed. It is effective for managing endometrial health (preventing unopposed oestrogen buildup) and for symptom management, and for some women is an appropriate and valuable part of their overall management.
The important clinical consideration is that the pill manages the symptom of irregular cycles without addressing the metabolic drivers. When it is stopped - for any reason - cycles typically revert to their pre-pill pattern unless the underlying insulin resistance and hormonal environment have shifted in the interim.
Metformin is an insulin-sensitising medication increasingly used in PCOS for cycle regulation. Its mechanism - reducing hepatic glucose output and improving insulin sensitivity - addresses the metabolic root more directly than the pill, and clinical evidence for improved ovulation rates and cycle regularity is consistent.⁶
Letrozole and clomiphene are ovulation-induction medications used specifically when pregnancy is the goal. They fall outside the scope of cycle regulation in the absence of fertility intent.
Clinical Insight
he menstrual cycle disruption of PCOS is mechanistically well-understood - driven by the interaction of insulin resistance, LH/FSH dysregulation, androgen excess, chronic inflammation, and HPA axis dysregulation that impairs the precise hormonal sequence required for ovulation. Anovulatory cycles in PCOS are not a fixed, inevitable feature of the condition. They are a metabolic output that responds to the same interventions that improve insulin sensitivity, reduce inflammatory load, and restore hormonal balance across the condition as a whole. The clinical evidence consistently shows that improving the metabolic environment in PCOS produces meaningful improvements in ovulation rates and cycle regularity - independent of weight loss - confirming that it is the hormonal environment, not body weight per se, that is the primary determinant of cycle function. Cycle regularity is both a quality-of-life outcome and a meaningful metabolic health indicator - one of the most accessible markers of how comprehensively the underlying condition is being addressed.
The Bottom Line
Irregular periods in PCOS are not just an inconvenience, and they are not simply "part of the condition" in a way that cannot be addressed. They are a metabolic signal - the visible output of an hormonal environment disrupted by insulin resistance, androgen excess, chronic inflammation, and HPA axis dysregulation.
Understanding that signal means understanding that cycle regularity is responsive to the same interventions that improve every other dimension of PCOS. As insulin sensitivity improves, LH/FSH balance gradually normalises. As inflammatory load reduces, the ovarian environment becomes more hospitable to follicle development. As cortisol regulation improves, the HPO axis is less suppressed. And as ovulation resumes, progesterone returns - with downstream benefits for mood, sleep, anxiety, and long-term hormonal health.
Your cycle is one of the most informative health metrics you have. It is worth paying attention to - not with anxiety, but with curiosity. It is telling you something real about your metabolic health, and it will tell you when that health is improving.
For the complete metabolic framework underpinning cycle health in PCOS: PCOS and Metabolism: The Complete Guide And for the foundational hormonal mechanism: PCOS and Insulin Resistance: What's Really Driving Your Symptoms
Ready to Address the Metabolic Root of Your Irregular Cycles?
In clinic, I work with women to address the insulin resistance, inflammatory load, and hormonal dysregulation that disrupt cycle regularity in PCOS - not just manage the symptom.
Our Metabolic Balance® programme uses your individual blood chemistry to design a personalised nutrition protocol that recalibrates insulin sensitivity and restores the hormonal environment in which regular ovulation becomes possible.
Improved cycle regularity is one of the outcomes women most consistently report through the programme - emerging alongside improvements in energy, skin, mood, and metabolic markers as the hormonal environment gradually shifts.
In-clinic and remote consultations available.
Free Resource - Start Here
The 7-Day Metabolic Reset is a free, structured guide for women with PCOS and insulin resistance - covering blood sugar stabilisation, anti-inflammatory nutrition, and practical daily strategies in a clear seven-day framework.
👉 Download the 7-Day Metabolic Reset
References
- Joham AE, et al. (2014). Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome. Fertility and Sterility, 102(1), 172–179.
- Palomba S, et al. (2015). Lifestyle interventions in PCOS: a systematic review of randomised controlled trials. Clinical Endocrinology, 83(3), 317–333.
- Unfer V, et al. (2017). Myo-inositol effects in women with PCOS: a meta-analysis of randomised controlled trials. Endocrine Connections, 6(8), 647–658.
- Irani M & Merhi Z. (2014). Role of vitamin D in ovarian physiology and its implication in reproduction. Fertility and Sterility, 102(2), 460–468.
- Nasr A. (2010). Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women. Reproductive BioMedicine Online, 20(3), 403–409.
- Tang T, et al. (2012). Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews, 5, CD003053.




